维普期刊资源整合服务平台（V6.5）

119篇 您的检索式：作者名="Hoogwerf"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial显示文摘	Faramarz Ismail-Beigi Timothy Craven Mary Ann Banerji Jan Basile Jorge Calles Robert M Cohen Robert Cuddihy William C Cushman Saul Genuth Richard H Grimm Bruce P Hamilton Byron Hoogwerf Diane Karl Lois Katz Armand Krikorian Patrick O'Connor Rodica Pop-Bus	2010	The Lancet2010，，9739：	2
2	Neuroglycopenic and other symptoms in patients with Insulinomas显示文摘	Dizon AM Kowalyk S Hoogwerf BJ	1999	Am J Med1999，106，：	1
3	Renin - angiotensin system blockade and cardiovas- cular and renal protection 显示文摘	Hoogwerf BJ	2010	Am J Cardiol2010，105，：	1
4	Ramipril and the development of diabetes显示文摘	Yusuf S Gerstein H Hoogwerf B		0，，：	1
5	Serum lipid and diabetic retinopathy显示文摘	CHEW EY HOOGWERF BJ	1996	Diabetes Care1996，19，：	1
6	Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy显示文摘	Lonn E Yusuf S Hoogwerf B	2002	Diabetes Care2002，25，11：	1
7	Serum lipid and diabetic retinopathy显示文摘	Femis FL Chew EY Hoogwerf BJ	1996	Diabetes Care1996，19，：	1
8	Neuroglycopenic and other- symptoms in patients with insulinomas显示文摘	Dizon AN Kowalyk S Hoogwerf BJ	1999	Am J Med1999，106，3：	1
9	Neuroglycopenic and other symptoms in patients with Insulinomas显示文摘	Dizon AM Kowalyk S Hoogwerf BJ	1999	Am J Med1999，106，：	1
10	Ramipril and the development of diabetes显示文摘	Gerstein H Hoogwerf B	2001	JAMA2001，286，15：	1
11	Renin-angiotensin system blockade and cardiovascular and renal protection显示文摘	Hoogwerf B J	2010	Am J Cardiol2010，105，1：	1
12	Effects of vitamin E on cardi- ovascular and microvascular outcomes in high-risk patients with diabetes:results of the HOPE study and MICRO-HOPE substudy 显示文摘	Lonn E Yusuf S Hoogwerf B	2002	Diabetes Care2002，25，11：	1
13	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon- like peptide I(GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
14	Risk of cardiovasculardisease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or otherglucose-lowering therapies a retrospective analysis of the LifeLinkdatabase显示文摘	Best JH Hoogwerf BJ Herman WH	2011	Diabetes Care2011，34，1：	1
15	Effect of exeuatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study 显示文摘	Gill A Hoogwerf B J Burger J	2010	Car- diovasc diabetol2010，9，：	1
16	HOPE study investigators, ramipil and the development of diabetes显示文摘	Yusuf S Gerstein H Hoogwerf B	2001	JAMA2001，286，：	1
17	Association of dyslipidemia and effects of statins on nonmacrovascular diseases显示文摘	Baghdasarian SB Jneid H Hoogwerf BJ	2004	Clin Ther2004，26，3：	1
18	Ramipril and the development of diabetes 显示文摘	Yusuf S Gerstein H Hoogwerf B	2001	JAMA2001，286，：	1
19	Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double?blind, placebo-controlled, randomized pilot study显示文摘	Gill A Hoogwerf BJ Burger J	2010	Cardiovascular Diabetology2010，9，：	1
20	The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes:a randomized trial显示文摘	Zinman B Hoogwerf BJ Duran Garcia S	2007	Ann Intern Med2007，146，7：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示